Compare Intuitive Surgical, Inc. (ISRG) vs JPMorgan Chase & Co (JPM) Price & Performance

Intuitive Surgical, Inc.Trade

JPMorgan Chase & CoTrade

Price performance (Past 24H)

Key statistics

Intuitive Surgical, Inc. vs JPMorgan Chase & Co — how do they compare? Intuitive Surgical, Inc. trades at $351.16 (market cap $125.08B), while JPMorgan Chase & Co trades at $345.21 (market cap $900.78B). The key difference: JPMorgan Chase & Co is far larger — about 7.2× Intuitive Surgical, Inc.'s market cap, and JPMorgan Chase & Co pays a 1.77% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.

	ISRG	JPM
Market Cap	$125.08B	$900.78B
Sector	Health	Financials
52-Week High	$592.85	$346.91
52-Week Low	$345.42	$282.84
Enterprise Value	$116.45B	—
Volume	—	10,479,943
Dividend Yield	—	1.77%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intuitive Surgical, Inc.

No Aura AI signal available yet.

JPMorgan Chase & Co

JPMorgan Chase & Co. (JPM) trades at $345.23, up 1.21% on the day, with a bullish technical outlook and strong analyst support. The stock shows robust fundamentals with revenue growth from $181.85B in 2025 to a projected $194.8B in 2026, though net income dipped slightly to $57.05B. Recent earnings beats in Q1 and Q2 2026 highlight operational strength, while a moderate buy consensus and $372.73 price target suggest upside potential amid geopolitical and economic uncertainties noted by CEO Jamie Dimon.

JPMorgan presents a favorable investment case driven by earnings momentum and sector leadership, but risks include volatile cash flows, rising cybersecurity threats, and macroeconomic headwinds. Institutional accumulation and a high ROE reinforce confidence, yet investors must weigh debt levels and interest rate sensitivity against the stock's current valuation near key resistance.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ISRG

Intuitive Surgical shares drop 38% amid U.S. procedure slowdowns and valuation concernsSeeking Alpha · 1 day agoBullish Intuitive Surgical stays a buy despite nearly 30% stock drop, with strong margins and growth outlook.Seeking Alpha · 3 days agoBullish Key stocks including Intuitive Surgical drop sharply on growth and dilution concernsRayan Ahmad · 4 days agoBearish View details →

JPM

JPMorgan CEO Dimon warns of risks in stocks and bonds, expects high bond yields amid geopolitical and fiscal challenges.Fox Business · 9 hours agoBearish JPMorgan CEO warns investors of underestimated geopolitical and fiscal risks, advises caution on stocks and long-term Treasurys.CNBC · 1 day agoBearish J.P. Morgan posts record Q2 with strong loan growth and rising book value per shareSeeking Alpha · 3 days agoBullish View details →

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

About JPMorgan Chase & Co

JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.